相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。General population normative data for the EORTC QLQ-C30 health-related quality of life questionnaire based on 15,386 persons across 13 European countries, Canada and the Unites States
S. Nolte et al.
EUROPEAN JOURNAL OF CANCER (2019)
Bevacizumab and temozolomide in patients with first recurrence of WHO grade II and III glioma, without 1p/19q co-deletion (TAVAREC): a randomised controlled phase 2 EORTC trial
Martin J. van den Bent et al.
LANCET ONCOLOGY (2018)
Lomustine and Bevacizumab in Progressive Glioblastoma
Wolfgang Wick et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Health-related quality of life in patients with high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study
Jaap C. Reijneveld et al.
LANCET ONCOLOGY (2016)
The impact of bevacizumab on health-related quality of life in patients treated for recurrent glioblastoma: Results of the randomised controlled phase 2 BELOB trial
Linda Dirven et al.
EUROPEAN JOURNAL OF CANCER (2015)
Health-Related Quality of Life in a Randomized Phase III Study of Bevacizumab, Temozolomide, and Radiotherapy in Newly Diagnosed Glioblastoma
Martin J. B. Taphoorn et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Health-related quality of life and cognitive functioning in longterm anaplastic oligodendroglioma and oligoastrocytoma survivors
Esther J. J. Habets et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial
Walter Taal et al.
LANCET ONCOLOGY (2014)
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
Mark R. Gilbert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Health-related Quality of Life in Patients with Brain Tumors: Limitations and Additional Outcome Measures
Linda Dirven et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2013)
Minimal clinically meaningful differences for the EORTC QLQ-C30 and EORTC QLQ-BN20 scales in brain cancer patients
J. Maringwa et al.
ANNALS OF ONCOLOGY (2011)
Compromised Health-Related Quality of Life in Patients With Low-Grade Glioma
Neil K. Aaronson et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients
Martin J. B. Taphoorn et al.
EUROPEAN JOURNAL OF CANCER (2010)
Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
Patrick Y. Wen et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Review on Quality of Life Issues in Patients with Primary Brain Tumors
Martin J. B. Taphoorn et al.
ONCOLOGIST (2010)
Quality, interpretation and presentation of European Organisation for Research and Treatment of Cancer quality of life questionnaire core 30 data in randomised controlled trials
Kim Cocks et al.
EUROPEAN JOURNAL OF CANCER (2008)
Health-related quality of life in patients treated for anaplastic oligodendroglioma with adjuvant chemotherapy:: Results of a European organisation for research and treatment of cancer randomized clinical trial
Martin J. B. Taphoorn et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Randomized phase II trial of erlotinib (E) versus temozolomide (TMZ) or BCNU in recurrent glioblastoma multiforme (GBM): EORTC 26034
M. J. Van Den Bent et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Beyond the development of health-related quality-of-life (HRQOL) measures: A checklist for evaluating HRQOL outcomes in cancer clinical trials - Does HRQOL evaluation in prostate cancer research inform clinical decision making?
F Efficace et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
分享论文
